MedPath

Incidence of active tuberculosis in latent tuberculosis infection end stage kidney disease patients waiting for kidney transplant treated with isoniazid and rifapentine 1 month

Conditions
ESRD patients on waiting list for kidney transplant who was tested IGRA with positive result.
Latent tuberculosis infection, transplantation, end stage kidney disease, isoniazid, rifapentine
Registration Number
TCTR20211213004
Lead Sponsor
Division of nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
260
Inclusion Criteria

1. Age >= 18 years old
2. Normal chest X-ray within 90 days
3. Body weight >= 35 kg
4. Laboratory investigations revealed
- AST and ALT < 3 x ULN
- Total bilirubin < 1.5 mg/d

Exclusion Criteria

1. Has sign or symptoms of active tuberculosis
2. During treatment of active tuberculosis
3. History of active tuberculosis treatment within 2 years
4. History of latent tuberculosis treatment within 2 years
5. History of isoniazid or rifampicin/rifapentine resistace
6. Cirrhosis
7 . Pregnancy or during breast feeding
8. HIV infection

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of active tuberculosis disease End of study Incidence
Secondary Outcome Measures
NameTimeMethod
Prevalence of latent tuberculosis infection Day 0 Prevalence
© Copyright 2025. All Rights Reserved by MedPath